Flunitazene

From WikiMD's WELLNESSPEDIA

Flunitrazepam is a benzodiazepine derivative drug that is commonly known as a potent hypnotic, sedative, anxiolytic, amnestic, and skeletal muscle relaxant drug. It is marketed under various trade names worldwide, including Rohypnol, Flunipam, and Hypnodorm, among others.

Pharmacology[edit]

Flunitrazepam is a benzodiazepine agonist, which means it enhances the effect of the neurotransmitter gamma-aminobutyric acid (GABA) at the GABA_A receptor, resulting in sedative, sleep-inducing, anxiolytic, anticonvulsant, and muscle relaxant properties.

Medical Uses[edit]

Flunitrazepam is primarily used for the short-term treatment of insomnia. It is also used as a premedication for surgical procedures to induce sleepiness, reduce anxiety, and impair memory to prevent recall of the procedure.

Side Effects[edit]

Common side effects of flunitrazepam include drowsiness, impaired coordination, dizziness, and confusion. Long-term use can result in tolerance, physical dependence, and withdrawal syndrome. It may also cause paradoxical effects like increased anxiety, agitation, and hallucinations.

Legal Status[edit]

In many countries, flunitrazepam is a controlled substance, meaning its use is restricted due to its potential for abuse and addiction. In the United States, it is a Schedule IV controlled substance under the Controlled Substances Act.

See Also[edit]

This article is a stub related to pharmacology. You can help WikiMD by expanding it!


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.